Cargando…
Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life
Pulmonary hypertension resulting from chronic lung disease such as chronic obstructive pulmonary disease and interstitial lung disease is categorized by the World Health Organization as Group 3 pulmonary hypertension. To identify the symptoms and impacts of World Health Organization Group 3 pulmonar...
Autores principales: | DuBrock, Hilary M., Nathan, Steven D., Reeve, Bryce B., Kolaitis, Nicholas A., Mathai, Stephen C., Classi, Peter M., Nelsen, Andrew C., Olayinka-Amao, Bimpe, Norcross, Lindsey N., Martin, Susan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020242/ https://www.ncbi.nlm.nih.gov/pubmed/33868642 http://dx.doi.org/10.1177/20458940211005641 |
Ejemplares similares
-
Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure
por: Highland, Kristin B., et al.
Publicado: (2021) -
Pulmonary hypertension in ANCA-associated vasculitis: A retrospective analysis
por: Baqir, Misbah, et al.
Publicado: (2023) -
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience
por: Anand, Vidhu, et al.
Publicado: (2019) -
Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms
por: Mathai, Stephen C., et al.
Publicado: (2019) -
Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease
por: Choi, Joon Young, et al.
Publicado: (2022)